1362 related articles for article (PubMed ID: 11043579)
1. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
2. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
3. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
Maggiolini M; Vivacqua A; Fasanella G; Recchia AG; Sisci D; Pezzi V; Montanaro D; Musti AM; Picard D; Andò S
J Biol Chem; 2004 Jun; 279(26):27008-16. PubMed ID: 15090535
[TBL] [Abstract][Full Text] [Related]
4. 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.
Kleuser B; Malek D; Gust R; Pertz HH; Potteck H
Mol Pharmacol; 2008 Dec; 74(6):1533-43. PubMed ID: 18768737
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.
Ram PT; Kiefer T; Silverman M; Song Y; Brown GM; Hill SM
Mol Cell Endocrinol; 1998 Jun; 141(1-2):53-64. PubMed ID: 9723886
[TBL] [Abstract][Full Text] [Related]
6. Proximal events in signaling by plasma membrane estrogen receptors.
Razandi M; Pedram A; Park ST; Levin ER
J Biol Chem; 2003 Jan; 278(4):2701-12. PubMed ID: 12421825
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
[TBL] [Abstract][Full Text] [Related]
8. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
Schmidt-Wolf R; Zissel G
Anticancer Res; 2020 Jun; 40(6):3097-3108. PubMed ID: 32487604
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice.
Singh M; Sétáló G; Guan X; Frail DE; Toran-Allerand CD
J Neurosci; 2000 Mar; 20(5):1694-700. PubMed ID: 10684871
[TBL] [Abstract][Full Text] [Related]
10. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway.
Marques SA; Dy LC; Southall MD; Yi Q; Smietana E; Kapur R; Marques M; Travers JB; Spandau DF
J Pharmacol Exp Ther; 2002 Mar; 300(3):1026-35. PubMed ID: 11861812
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
12. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine 1-phosphate activates Erk-1/-2 by transactivating epidermal growth factor receptor in rat-2 cells.
Kim JH; Kim JH; Song WK; Kim JH; Chun JS
IUBMB Life; 2000 Aug; 50(2):119-24. PubMed ID: 11185956
[TBL] [Abstract][Full Text] [Related]
14. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
15. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
16. Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: roles of protein kinase Cdelta, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation.
Shah BH; Catt KJ
Mol Pharmacol; 2002 Feb; 61(2):343-51. PubMed ID: 11809859
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer.
Filardo EJ
J Steroid Biochem Mol Biol; 2002 Feb; 80(2):231-8. PubMed ID: 11897506
[TBL] [Abstract][Full Text] [Related]
18. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30.
Quinn JA; Graeber CT; Frackelton AR; Kim M; Schwarzbauer JE; Filardo EJ
Mol Endocrinol; 2009 Jul; 23(7):1052-64. PubMed ID: 19342448
[TBL] [Abstract][Full Text] [Related]
19. Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells.
Ahola TM; Alkio N; Manninen T; Ylikomi T
Endocrinology; 2002 Dec; 143(12):4620-6. PubMed ID: 12446589
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta.
Keshamouni VG; Mattingly RR; Reddy KB
J Biol Chem; 2002 Jun; 277(25):22558-65. PubMed ID: 11960991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
